# Kodiak Sciences Inc. (KOD) stock: price and valuation

URL: https://funkfolio.com/stock/KOD

> Kodiak Sciences Inc. (KOD) trades at $96.62 and is worth $6.32B. Valuation against its own history and up to 20 years of financials.

---

## Kodiak Sciences Inc. (KOD)

Kodiak Sciences Inc. (KOD) is a healthcare company (biotechnology) based in the United States. The share price is $96.62, down 4.08% on the day, which values the company at $6.32B. Price as of 17 Nov 2026, 20:31 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $96.62 −4.08% today
- **Market value:** $6.32B
- **200-week average:** $15.24 534% above
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 20:31 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Kodiak Sciences Inc. in more detail

KOD trades at -26.7× next year's expected earnings. It sits 534% above its 200-week average of $15.24.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

2 of the superinvestors tracked here hold KOD, including Julian and Felix Baker (3.9% of the portfolio), Polen Capital team (0.0% of the portfolio).

### Superinvestors holding KOD

2 of the investors tracked here report a position in their latest 13F filing.

- [Julian and Felix Baker Baker Bros. Advisors](https://funkfolio.com/gurus/baker-brothers) 3.89% of portfolio · $776.1M · Q2 2026
- [Polen Capital team Polen Capital Management](https://funkfolio.com/gurus/polen-capital) 0.03% of portfolio · $2.3M · trimmed · Q3 2026

### Health Care companies of similar size

- [Immunovant IMVT](https://funkfolio.com/stock/IMVT)
- [Axsome Therapeutics AXSM](https://funkfolio.com/stock/AXSM)
- [Chemed CHE](https://funkfolio.com/stock/CHE)
- [Oruka Therapeutics ORKA](https://funkfolio.com/stock/ORKA)
- [Arrowhead Pharmaceuticals ARWR](https://funkfolio.com/stock/ARWR)
- [MSA Safety MSA](https://funkfolio.com/stock/MSA)
- [CG Oncology CGON](https://funkfolio.com/stock/CGON)
- [Lantheus Holdings LNTH](https://funkfolio.com/stock/LNTH)
- [RadNet RDNT](https://funkfolio.com/stock/RDNT)
- [Belite Bio BLTE](https://funkfolio.com/stock/BLTE)
- [Ligand Pharmaceuticals LGND](https://funkfolio.com/stock/LGND)
- [Scholar Rock Holding SRRK](https://funkfolio.com/stock/SRRK)

Side by side: [KOD vs CGON (Kodiak Sciences Inc. vs CG Oncology)](https://funkfolio.com/compare/cgon-vs-kod) [KOD vs LNTH (Kodiak Sciences Inc. vs Lantheus Holdings)](https://funkfolio.com/compare/kod-vs-lnth) [KOD vs MSA (Kodiak Sciences Inc. vs MSA Safety)](https://funkfolio.com/compare/kod-vs-msa) [KOD vs ARWR (Kodiak Sciences Inc. vs Arrowhead Pharmaceuticals)](https://funkfolio.com/compare/arwr-vs-kod) [KOD vs ORKA (Kodiak Sciences Inc. vs Oruka Therapeutics)](https://funkfolio.com/compare/kod-vs-orka)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Kodiak Sciences Inc. (KOD): questions and answers

**What is Kodiak Sciences Inc.'s market cap?**

Kodiak Sciences Inc. is valued at $6.32B at a share price of $96.62.

**Is KOD above its 200-week moving average?**

Yes. KOD is 534.1% above its 200-week average of $15.24. Long-term investors watch that line because strong companies rarely trade below it for long.

**Does KOD pay a dividend?**

Kodiak Sciences Inc. does not currently pay a regular dividend.

**Which famous investors own KOD?**

In their latest quarterly filings, Julian and Felix Baker (3.9% of the portfolio), Polen Capital team (0.0% of the portfolio) hold KOD. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Kodiak Sciences Inc. (KOD) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/KOD

Underlying data: Yahoo Finance; company filings with the SEC.
